Browse diseases

…h in vitro and in vivo. Clinically, higher AGPAT3 expression in tumors was associated with increased immune activation and improved ov…

… repertoires across distinct anatomical compartments, including tumors, blood, and lymph nodes. Such analyses yield insights into tiss…

…hermore, the immune temperature correlates with LRC after RT in NSCLC. Patients who achieved LRC had significantly higher immune temp…

… activation. However, RT also suppresses the immune response to tumors through lymphodepletion, reduced lymphocyte reactivity, and unf…

…ce and humans. We show that PDS01ADC treatment in patients with advanced solid tumors boosts peripheral T cells with stem-like and activated characte…

…tor of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene 2015;34(39):5069-79.Haydar D, et al. Cell-surface ant…

…ent EZH2 inhibitor, is FDA-approved for epithelioid sarcoma and follicular lymphoma and is under investigation in multiple solid and liquid tumors.…

… V12.6) to obtain expression data of the β6 integrin across The Cancer Genome Atlas (TCGA).Results High expression of β6 integrin mRNA…

… have the potential to reinvigorate the immune response against tumors and address shortcomings of checkpoint inhibition. We are devel…

…acy in preclinical models, demonstrating the potential to treat cancers resistant to conventional immune checkpoint inhibitors (ICIs) a…

… effectiveness of antitumor therapies, including immunotherapy. Tumors alter the expansion and functions of myeloid cells by acting lo…

…played by the prototypic T cell co-stimulatory receptor CD28 in cancer immunotherapy. Inhibition of co-stimulation by direct competiti…